Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation.
暂无分享,去创建一个
[1] T. Cresteil,et al. Delayed ontogenesis of CYP1A2 in the human liver. , 1998, European journal of biochemistry.
[2] H J Clewell,et al. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). , 1993, Toxicology letters.
[3] D G Gray,et al. A physiologically based pharmacokinetic model for methyl mercury in the pregnant rat and fetus. , 1995, Toxicology and applied pharmacology.
[4] Harvey J Clewell,et al. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[5] Tammie R. Covington,et al. Evaluation of the Potential Impact of Age- and Gender-Specific Lung Morphology and Ventilation Rate on the Dosimetry of Vapors , 2003, Inhalation toxicology.
[6] M E Andersen,et al. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation. , 1997, Toxicology and applied pharmacology.
[7] H J Clewell,et al. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[8] K. Ward,et al. Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice. , 1997, Toxicology and applied pharmacology.
[9] Harvey J Clewell,et al. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. , 2002, Regulatory toxicology and pharmacology : RTP.
[10] Harvey J. Clewell,et al. Evaluation of the Uncertainty in an Oral Reference Dose for Methylmercury Due to Interindividual Variability in Pharmacokinetics , 1999, Risk analysis : an official publication of the Society for Risk Analysis.
[11] R. J. Nolan,et al. In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human , 2005, Archives of Toxicology.
[12] M. Neville,et al. Nutrient intake by breast-fed infants during the first five days after birth. , 1986, American journal of diseases of children.
[13] D Mahle,et al. Lactational transfer of volatile chemicals in breast milk. , 1997, American Industrial Hygiene Association journal.
[14] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[15] Sun Ku Lee,et al. Comparison of pharmacokinetic interactions and physiologically based pharmacokinetic modeling of PCB 153 and PCB 126 in nonpregnant mice, lactating mice, and suckling pups. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[16] M Pelekis,et al. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. , 2001, Regulatory toxicology and pharmacology : RTP.
[17] P. Pikkarainen,et al. Development of Alcohol Dehydrogenase Activity in the Human Liver , 1967, Pediatric Research.
[18] R B Conolly,et al. Transplacental and lactational transfer of p,p'-DDE in Sprague-Dawley rats. , 1999, Toxicology and applied pharmacology.
[19] D. H. Taylor,et al. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1990, Toxicology and applied pharmacology.
[20] Harvey J. Clewell,et al. Review and Evaluation of the Potential Impact of Age- and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry , 2002, Critical reviews in toxicology.
[21] M. Brodie,et al. Tissue and species differences in enzymes of epoxide metabolism. , 1981, Xenobiotica; the fate of foreign compounds in biological systems.
[22] Sorell L. Schwartz,et al. A physiologically based pharmacokinetic model for nicotine and cotinine in man , 1992, Journal of Pharmacokinetics and Biopharmaceutics.
[23] T. Cresteil,et al. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. , 1996, European journal of biochemistry.
[24] Rebecca A Clewell,et al. Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure. , 2002, Environmental health perspectives.
[25] J. Konz,et al. Exposure factors handbook , 1989 .
[26] John F. Young,et al. A physiologically based pharmacokinetic computer model for human pregnancy. , 1994, Teratology.
[27] John E. Murphy,et al. An in vitro method for determination of tissue partition coefficients of non‐volatile chemicals such as 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin and estradiol , 1995, Journal of applied toxicology : JAT.
[28] H J Clewell,et al. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. , 2001, The Science of the total environment.
[29] K Walton,et al. An analysis of the need for an additional uncertainty factor for infants and children. , 2000, Regulatory toxicology and pharmacology : RTP.
[30] J. Fisher,et al. A computer program linking physiologically based pharmacokinetic model with cancer risk assessment for breast-fed infants. , 1995, Computer methods and programs in biomedicine.
[31] W. S. Snyder,et al. Report of the task group on reference man , 1979, Annals of the ICRP.
[32] T. Cresteil,et al. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. , 1997, Pharmacogenetics.
[33] J W Fisher,et al. Lactational transfer of tetrachloroethylene in rats. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.